Dov Elefant
CIK 1326487 · Chief Financial Officer · last filed 2026-03-27
Dov Elefant is a Chief Financial Officer who has filed 19 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for FEMY, was dated Mar 27, 2026. Across all open-market trades the lifetime net is +$15.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $244.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$244.3K
4
19
$15.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FEMY | Chief Financial Officer | 58,436 | $4.18 | $244.3K | $0 | 9 | 2026-03-27 |
| CLRB | Chief Financial Officer | — | $2.23 | — | $0 | 1 | 2022-01-27 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Financial Officer | 11,755 | $0.12 | $1.4K | $15.0K | 6 | 2021-03-05 |
| AKTX | Chief Financial Officer | — | $13.40 | — | $0 | 1 | 2015-09-22 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-27 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2026-02-20 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2025-11-12 | FEMY | Disc (I) | — | $0 | EDGAR |
| 2025-08-28 | FEMY | Disc (I) | +38,828 | $0 | EDGAR |
| 2025-06-04 | FEMY | Disc (I) | +19,608 | $20.0K | EDGAR |
| 2025-01-30 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2022-03-01 | FEMY | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | CLRB | Grant (A) | — | $0 | EDGAR |